Emerging Markets Power Boston Scientific: Will the Growth Trend Continue?

Key Takeaways Boston Scientific saw 9.8% operational sales growth in emerging markets in Q1 2025 despite geopolitical risks. BSX benefits from favorable economic trends, healthcare infrastructure and sustained investment. BSX competes with ABT and MDT, which also report strong emerging market growth and localization efforts.Emerging markets remain a vital growth engine for Boston Scientific Corporation (BSX) , anchoring the company’s broader international strategy and long-term expansion plans. In the fir ...